Cargando…
Monitoring cancer prognosis, diagnosis and treatment efficacy using metabolomics and lipidomics
INTRODUCTION: Cellular metabolism is altered during cancer initiation and progression, which allows cancer cells to increase anabolic synthesis, avoid apoptosis and adapt to low nutrient and oxygen availability. The metabolic nature of cancer enables patient cancer status to be monitored by metabolo...
Autores principales: | Armitage, Emily G., Southam, Andrew D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4987388/ https://www.ncbi.nlm.nih.gov/pubmed/27616976 http://dx.doi.org/10.1007/s11306-016-1093-7 |
Ejemplares similares
-
Distinguishing between the metabolome and xenobiotic exposome in environmental field samples analysed by direct-infusion mass spectrometry based metabolomics and lipidomics
por: Southam, Andrew D., et al.
Publicado: (2014) -
Lipidomics for diagnosis and prognosis of pulmonary hypertension
por: Bordag, Natalie, et al.
Publicado: (2023) -
Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy
por: Beyoğlu, Diren, et al.
Publicado: (2020) -
Enantioselectivity Effects in Clinical Metabolomics and Lipidomics
por: Oliveira, Regina V., et al.
Publicado: (2021) -
Contribution of Metabolomics to Multiple Sclerosis Diagnosis, Prognosis and Treatment
por: Rispoli, Marianna Gabriella, et al.
Publicado: (2021)